A prodrug form of omidenepag
Related Products
Active Metabolite(s)
41045Omidenepag (free acid)
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Omidenepag Isopropyl

Item No. 41046

Technical Information
Formal Name
N-[6-[[[[4-(1H-pyrazol-1-yl)phenyl]methyl](3-sulfonyl)amino]methyl]-2-pyridinyl]-glycine, 1-methylethyl ester
CAS Number
1187451-19-9
Synonyms
  • DE 117
  • OMDI
Molecular Formula
C26H28N6O4S
Formula Weight
Purity
≥95%
Formulation
A solid
DMSO: Sparingly soluble: 1-10 mg/ml
SMILES
O=[S](N(CC1=CC=C(N2C=CC=N2)C=C1)CC3=CC=CC(NCC(OC(C)C)=O)=N3)(C4=CN=CC=C4)=O
InChi Code
InChI=1S/C26H28N6O4S/c1-20(2)36-26(33)17-28-25-8-3-6-22(30-25)19-31(37(34,35)24-7-4-13-27-16-24)18-21-9-11-23(12-10-21)32-15-5-14-29-32/h3-16,20H,17-19H2,1-2H3,(H,28,30)
InChi Key
VIQCWEGEHRBLAC-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Lipid Resource Center
    Discover Products & Resources for Lipid Research
    • High-purity lipid standards
    • Lipid roles in biology
    • Lipids in health & disease
    • Lipids for pharmaceutical development
    • Protocols, advice, & resources
    EXPLORE NOW
    Product Description

    Omidenepag isopropyl is a prodrug form of omidenepag (Item No. 41045), a non-prostaglandin agonist of the prostaglandin E2 (PGE2) receptor subtype EP2.1 It reduces intraocular pressure (IOP) in ocular normotensive and laser-induced ocular hypertensive cynomolgus monkeys when topically administered at a concentration of 0.01%/eye.1,2 Formulations containing omidenepag isopropyl have been used in the treatment of open-angle glaucoma and ocular hypertension.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Iwamura, R., Tanaka, M., Okanari, E., et alIdentification of a selective, non-prostanoid EP2 receptor agonist for the treatment of glaucoma: Omidenepag and its prodrug omidenepag isopropyl. J. Med. Chem. 61(15), 6869-6891 (2018).

    2. Kirihara, T., Taniguchi, T., Yamamura, K., et alPharmacologic characterization of omidenepag isopropyl, a novel selective EP2 receptor agonist, as an ocular hypotensive agent. Invest. Ophthalmol. Vis. Sci. 59(1), 145-153 (2018).